Sang Hoon Chun

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Byoung Chul Cho, Ji‐Youn Han, Sang‐We Kim et al. · Journal of Thoracic Oncology · 2021 · 91 citations · Full text

Medicine, Oncology, Pharmacology +13

QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth

Eun Ju Kim, Jeong Seon Kim, Sieun Lee et al. · International Journal of Cancer · 2019 · 75 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells

Sieun Lee, Ji Hyung Hong, Jeong Seon Kim et al. · Cancer Letters · 2021 · 72 citations

Medicine, Molecular Biology, Oncology +15

Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma

Hye Sung Won, Chan Kwon Jung, Sang Hoon Chun et al. · Oral Oncology · 2012 · 49 citations

Medicine, Cancer Biology, Oral Pathology +9

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma

Sun Min Lim, Sang‐Hee Cho, In Gyu Hwang et al. · Cancer Research and Treatment · 2018 · 45 citations · Full text

Medicine, Molecular Medicine, Oncology +17